TherapeuticsMD (TXMD) Current Leases (2019 - 2020)
TherapeuticsMD's (TXMD) quarterly Current Leases came in at $2.3 million in Q4 2020, up 50.11% YoY from $1.5 million in Q1 2020, and down 6.25% on a QoQ basis from $2.4 million in Q3 2020.
TherapeuticsMD (TXMD) Current Leases (2019 - 2020) Analysis & Trends
TherapeuticsMD (TXMD) has 2 years of Current Leases data on file, last reported at $2.3 million in Q4 2020.
- Quarterly Current Leases rose 50.11% year-over-year to $2.3 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.3 million (up 50.11% YoY) and the FY2020 annual result came in at $2.3 million, up 50.11% from the prior year.
- Current Leases retreated to $2.3 million in Q4 2020, from $2.4 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.4 million in Q3 2020 to a low of $1.2 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 2.11 Mn |
| Mar 31, 2020 | 1.75 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.16 Mn |